SLC2A1 and neoplasm: Although we did not observe such effects in our in vitro models, lactate levels were increased in the drug-resistant xenografts and the concomitant upregulation of the glucose transporter GLUT-1 in CALR relative to CALS tumours is consistent with a switch to glycolytic metabolism.